Skip to content
‹ Back to IndustriesSciences

This Season’s Mission Will Be Making Space Relatable

Space to Grow is back for a second season with hosts Chris Blackerby and Charity Weeden from Astroscale. It’s where economics, technology and sustainability in space intersect. In the opening episode, Blackerby and Weeden take a look back and forward regarding the space economy. “We’re going to focus a lot on partnerships as a dedicated…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Chris Blackerby · · AstroscaleJames Webb Space TelescopePartnershipsPolicy
Share

Key takeaways

01

Space to Grow is back for a second season with hosts Chris Blackerby and Charity Weeden from Astroscale.

02

It’s where economics, technology and sustainability in space intersect.

03

In the opening episode, Blackerby and Weeden take a look back and forward regarding the space economy.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Space to Grow is back for a second season with hosts Chris Blackerby and Charity Weeden from Astroscale. It’s where economics, technology and sustainability in space intersect. In the opening episode, Blackerby and Weeden take a look back and forward regarding the space economy.

“We’re going to focus a lot on partnerships as a dedicated theme of conversations, as they are driving the space economy,” Blackerby said.

Since space exploration and sustainability are such complex initiatives, partnerships are critical.

Blackerby and Weeden shared some big moments in space from the last year. “Even with COVID, it was an incredible year for space,” Blackerby noted.

Weeden’s top moment was humanity in space. “Private citizens went into space. That’s a first, and everyone can relate to that.”

While that was a pivotal moment, others demonstrated risks and challenges, spawning from geopolitical impacts on Earth. One of those is the Russian ASAT (anti-satellite weapon) tests.

Turning back to good news that demonstrates cooperation and collaboration, the James Webb Space Telescope launched through a partnership between the U.S. and Europe. Weeden relayed that the investment in the space economy isn’t slowing in other good news. It’s actually growing.

The hosts then provided a preview of what’s to come this season. They’ll welcome a diverse group of guests from around the world. Topics will range from business to policy to technology.

Weeden also announced a new segment Space to Grow After Hours. “We’ll be debating topics with the pros and cons in this extra content,” she described.

More in This Series

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

CB
Chris Blackerby
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Takara Bio and SPT Labtech pair SMART-Seq kits with firefly automation scripts

Takara Bio and SPT Labtech pair SMART-Seq kits with firefly automation scripts

SPT Labtech and Takara Bio USA are teaming up to offer validated, automated workflows for library preparation, pairing Takara Bio's NGS library prep chemistries with the firefly liquid handler from SPT Labtech. Two SMART-Seq kits are available for download today. Due to ship in January 2027, the SMART-Seq mRNA Long Read Extended kit is set to be the first product to launch with a workflow tuned for firefly automation.

  • 01For sequencing cores on SPT Labtech's firefly, Takara Bio says automated workflows will be built into new kits from the start, which suggests more of the method-building could happen at the vendors before the box reaches the bench.
  • 02Whether DNA-seq and immune profiling kits arrive with firefly scripts on their launch dates will show if this becomes standard practice or stays an RNA-seq offering.

Nov 3, 2026

Crown Bioscience Appoints Guy Sheets as Senior Vice President, Commercial

Crown Bioscience appointed Guy Sheets as Senior Vice President, Commercial, bringing over 30 years of pharma and life sciences experience to lead the CRO's global commercial strategy. Sheets previously held senior commercial roles at QPS Holdings, CenExel, SGS Health Sciences, Lonza, and Thermo Fisher Scientific.

  • 01Guy Sheets brings 30+ years of commercial leadership across pharma, biotech, and life sciences, most recently as VP, Head of Global Business Development at QPS Holdings
  • 02Crown Bioscience operates 9 facilities across the US, Europe, and APAC with a portfolio of 2,800+ patient-derived xenograft models and 1,000+ tumor organoid models across 35 cancer indications
  • 03Sheets will lead Crown Bioscience’s global commercial strategy to drive growth, expand market presence, and strengthen client partnerships

Nov 3, 2026

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck has invested more than €300 million in a new bioprocessing production center in Daejeon, South Korea. It is the largest life science investment Merck has made in the region to date. The 44,500-square-meter facility makes cell culture media, process liquids and sterile sampling products to support biologics manufacturing from development through commercial supply.

  • 01A single Asia-Pacific site now supplies both small custom pre-GMP media and commercial-scale media, so a regional biologics program could scale without switching to a source outside the region.
  • 02Daejeon supplies cell culture media, process liquids, ready-to-use cleaning-in-place solutions and sterile sampling products.
  • 03The useful supplier question has moved past whether Merck has an Asia-Pacific plant: ask which product lines ship from Daejeon and what batch traceability data customers can see.

Nov 3, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

CB
Chris Blackerby

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512